Tumor endothelial marker 7 (TEM-7): A novel target for antiangiogenic therapy

被引:22
|
作者
Bagley, Rebecca G. [1 ]
Rouleau, Cecile [1 ]
Weber, William [1 ]
Mehraein, Khodadad [2 ]
Smale, Robert [2 ]
Curiel, Maritza [2 ]
Callahan, Michelle [1 ]
Roy, Andre [1 ]
Boutin, Paula [1 ]
St Martin, Thia [1 ]
Nacht, Mariana [1 ]
Teicher, Beverly A. [1 ]
机构
[1] Genzyme Corp, Framingham, MA 01701 USA
[2] Genzyme Genet, Los Angeles, CA 90066 USA
关键词
EXTRACELLULAR-MATRIX; PRECURSOR CELLS; EXPRESSION; CANCER; IDENTIFICATION; ANGIOGENESIS; CONTRIBUTE; CORTACTIN; PROTEINS; GROWTH;
D O I
10.1016/j.mvr.2011.09.004
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Antiangiogenesis has been validated as a therapeutic strategy to treat cancer, however, a need remains to identify new targets and therapies for specific diseases and to improve clinical benefit from antiangiogenic agents. Tumor endothelial marker 7 (TEM-7) was investigated as a possible target for therapeutic antiangiogenic intervention in cancer. TEM-7 expression was assessed by in situ hybridization or by immunohistochemistry (IHC) in 130 formalin-fixed paraffin-embedded (FFPE) and 410 frozen human clinical specimens of cancer plus 301 normal tissue samples. In vitro TEM-7 expression was evaluated in 4 human endothelial cell models and in 32 human cancer cell lines by RT-PCR and flow cytometry. An anti-TEM-7 antibody was tested in vitro on human SKOV3 ovarian and MDA-MB-231 breast carcinoma cells that expressed TEM-7 in antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis assays. In frozen tumor tissues, TEM-7 mRNA and protein was detected in all but one of the cancer types tested and was infrequently expressed in normal frozen tissues. In FFPE tumor tissues. TEM-7 protein was detected by IHC in colon, breast, lung, bladder, ovarian and endometrial cancers and in sarcomas. TEM-7 protein was not detected in head and neck, prostate or liver cancers. TEM-7 expression was restricted to the vasculature and was absent from tumor cells. In vitro, TEM-7 was not detected in human microvascular endothelial cells (HMVEC) or human umbilical vein endothelial cells (HUVEC) but was induced in endothelial precursor/progenitor cells (EPC) in the presence of the mitogen phorbol ester PMA. An anti-TEM-7 antibody mediated ADCC and phagocytosis in SKOV3 and MDA-MB-231 cell lines infected with an adenovirus expressing TEM-7. These data demonstrate that TEM-7 is a vascular protein associated with angiogenic states. TEM-7 is a novel and attractive target for antiangiogenic therapy. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:253 / 262
页数:10
相关论文
共 50 条
  • [31] Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy
    Gately, S
    Li, WW
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 2 - 11
  • [32] Mucin 7 (MUC7) as a new urinary tumor marker for bladder cancer
    Retz, MM
    Lehmann, J
    Amann, E
    Gerber, M
    Wullich, B
    Stöckle, M
    JOURNAL OF UROLOGY, 2002, 167 (04): : 165 - 165
  • [33] Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system
    Maishi, Nako
    Sakurai, Yu
    Hatakeyama, Hiroto
    Umeyama, Yui
    Nakamura, Takashi
    Endo, Rikito
    Alam, Mohammad Towfik
    Li, Cong
    Annan, Dorcas Akuba-Muhyia
    Kikuchi, Hiroshi
    Morimoto, Hirofumi
    Morimoto, Masahiro
    Akiyama, Kosuke
    Ohga, Noritaka
    Hida, Yasuhiro
    Harashima, Hideyoshi
    Hida, Kyoko
    CANCER SCIENCE, 2022, 113 (05) : 1855 - 1867
  • [34] IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer
    Yi, Xianyanling
    Zheng, Xiaonan
    Xu, Hang
    Li, Jin
    Zhang, Tianyi
    Ge, Peng
    Liao, Dazhou
    Li, Hong
    Lyu, Xiaoyan
    Ai, Jianzhong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma
    Haas, Tobias L.
    Sciuto, Maria Rita
    Brunetto, Lidia
    Valvo, Cecilia
    Signore, Michele
    Fiori, Micol E.
    di Martino, Simona
    Giannetti, Stefano
    Morgante, Liliana
    Boe, Alessandra
    Patrizii, Michele
    Warnken, Uwe
    Schnoelzer, Martina
    Ciolfi, Andrea
    Di Stefano, Chiara
    Biffoni, Mauro
    Ricci-Vitiani, Lucia
    Pallini, Roberto
    De Maria, Ruggero
    CELL STEM CELL, 2017, 21 (01) : 35 - +
  • [36] Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
    de Bernardi, Axel
    Dufresne, Armelle
    Mishellany, Florence
    Blay, Jean-Yves
    Ray-Coquard, Isabelle
    Brahmi, Mehdi
    CANCERS, 2022, 14 (04)
  • [37] Expression Profile of Tumor Endothelial Marker 7 and a Putative Ligand in the Rat Spinal Cord and Dorsal Root Ganglion
    Wang, Lih
    Lee, Kyu-Yeol
    Park, Hwan-Tae
    Kang, Dong-Sik
    ASIAN SPINE JOURNAL, 2007, 1 (02) : 65 - 74
  • [38] Can Metabotropic Glutamate Receptor 7 (mGluR 7) be a Novel Target for Analgesia?
    Shivaprakash, G.
    Suvarna, Punya
    Hadigal, Sanjay
    Kamath, Priyanka
    Prabhu, Natesh
    Shenoy, Ashok K.
    Pallavi, L. C.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (09) : HC16 - HC18
  • [39] Nuclear magnetic resonance imaging of tumour growth and neovasculature performance in vivo reveals Grb7 as a novel antiangiogenic target
    Garcia-Palmero, Irene
    Lopez-Larrubia, Pilar
    Cerdan, Sebastian
    Villalobo, Antonio
    NMR IN BIOMEDICINE, 2013, 26 (09) : 1059 - 1069